PharmaGap Home Contact Us
top line
sepsepDiscovery EnginesepPartnering

Management Team

Robert C. McInnis, President & Chief Executive Officer
Bob joined PharmaGap in December 2004. Prior to this, Bob was the Director of Financial Programs at World Heart Corporation, dealing with various financial structuring programs including responsibility for U.S. and Canadian capital markets regulatory affairs. Previously, Bob was president of SC Stormont Corporation and was involved in the corporate financial management for the Ottawa Senators Hockey Club and The Corel Centre. Before that, Bob was employed at SHL Systemhouse Inc., at the time, Canada’s largest computer system integration company where he held a number of key financial management roles including corporate structuring, and mergers and acquisitions activity. Bob is a chartered accountant and holds a Bachelor of Mathematics degree from the University of Waterloo.

Jenny Phipps, Ph.D., Chief Scientific Officer, Director
Co-founder of PharmaGap. Jenny is an experienced molecular biologist with a strong interest in signal transduction processes and their effect on disease. As CSO, Jenny designed and implemented the core drug development program targeting PKC. Before joining the Company full-time in 2001, Jenny was a senior researcher at the National Research Council of Canada in Ottawa, an adjunct professor at the University of Ottawa (School of Medicine) and an assistant professor of biology at Carleton University (Ottawa). She has a Doctorate (Molecular Genetics) from the Universite Paul Sabatier (France).

Gerald Leahy, Chief Financial Officer
Gerald joined Pharmagap as Chief Financial Officer in December, 2004 bringing more than 20 years of industry experience in public and private companies, including 14 years in the high-tech sector. As a financial professional he has successfully developed and managed finance groups throughout the building and growth stages of companies. He has been involved in private and public financings, international expansion into foreign markets as well as reorganizations. Gerald was a key player in Simware Inc.’s Nasdaq IPO and the eventual merger with Netmanage Inc., and also recently acted as CFO during Linmor Inc.’s strategic sale to Nuvo Network Management Inc. Gerald is a CMA and holds a Bachelor of Commerce degree from Carleton University.

Company Overview

arrow
Management Team
arrow
Board of Directors
footer